Scott Wieland

2014

In 2014, Scott Wieland earned a total compensation of $951K as Senior Vice President – Drug Development at CytRx, a 35% increase compared to previous year.

Compensation breakdown

Bonus$300,000
Option Awards$301,000
Salary$350,000
Total$951,000

Wieland received $350K in salary, accounting for 37% of the total pay in 2014.

Wieland also received $300K in bonus and $301K in option awards.

Rankings

In 2014, Scott Wieland's compensation ranked 7,818th out of 13,032 executives tracked by ExecPay. In other words, Wieland earned more than 40.0% of executives.

ClassificationRankingPercentile
All
7,818
out of 13,032
40th
Division
Manufacturing
2,892
out of 4,966
42nd
Major group
Chemicals And Allied Products
986
out of 1,686
42nd
Industry group
Drugs
774
out of 1,365
43rd
Industry
Biological Products, Except Diagnostic Substances
136
out of 236
42nd
Source: SEC filing on May 20, 2016.

Wieland's colleagues

We found four more compensation records of executives who worked with Scott Wieland at CytRx in 2014.

2014

Steven Kriegsman

CytRx

Chief Executive Officer

2014

Daniel Levitt

CytRx

Chief Medical Officer

2014

John Caloz

CytRx

Chief Financial Officer

2014

Benjamin Levin

CytRx

General Counsel

You may also like